Replimune (REPL) Return on Equity (2018 - 2025)

Replimune has disclosed Return on Equity across 8 years of filings, most recently posting 0.01% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.01%, down 1.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (down 1.0% YoY), and the FY2025 annual result was 0.01%, changed 0.0% from the prior year.
• Return on Equity came in at 0.01% for Q4 2025 at Replimune, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2025.
• The 5-year median for Return on Equity is 0.0% (2022), against an average of 0.0%.
• Across the five-year window, Return on Equity changed 0 bps in 2021 and fell 1 bps in 2025, its largest moves.
• Replimune's Return on Equity stood at 0.0% in 2021, then slumped by 33 bps to 0.0% in 2022, then sank by 48 bps to 0.0% in 2023, then dropped by 12 bps to 0.01% in 2024, then plunged by 151 bps to 0.01% in 2025.
• The last three Return on Equity figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.